 | • レポートコード：D005-00521 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、人工多能性幹細胞の世界市場を広く調査・分析し、今後の市場展望をまとめております。人工多能性幹細胞の種類別市場規模（肝細胞、線維芽細胞、ケラチノサイト、羊膜細胞、その他）、用途別市場規模（学術研究、医薬品開発＆発見、毒性スクリーニング、再生医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Fujifilm Holding Corporation、Acelity Holdings、Bristol-Myers Squibb Company、Astellas Pharma、Aastrom Biosciences、Fate Therapeutics、Japan Tissue Engineering、Celgene Corporation、ViaCyte、StemCells、Organogenesis ・地域別グローバル市場分析 2015年-2020年 ・人工多能性幹細胞の北米市場（アメリカ、カナダ、メキシコ） ・人工多能性幹細胞のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・人工多能性幹細胞のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・人工多能性幹細胞の南米市場（ブラジル、アルゼンチン） ・人工多能性幹細胞の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：肝細胞、線維芽細胞、ケラチノサイト、羊膜細胞、その他 ・用途別分析：学術研究、医薬品開発＆発見、毒性スクリーニング、再生医療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Induced Pluripotent Stem Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.7% in the forecast period of 2020 to 2025 and will expected to reach USD 130.7 million by 2025, from USD 84 million in 2019.
The Induced Pluripotent Stem Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Induced Pluripotent Stem Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Induced Pluripotent Stem Cells market has been segmented into:
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
By Application, Induced Pluripotent Stem Cells has been segmented into:
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Induced Pluripotent Stem Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Induced Pluripotent Stem Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Induced Pluripotent Stem Cells market.
The report offers in-depth assessment of the growth and other aspects of the Induced Pluripotent Stem Cells market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Induced Pluripotent Stem Cells Market Share Analysis
Induced Pluripotent Stem Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Induced Pluripotent Stem Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Induced Pluripotent Stem Cells sales, revenue and market share for each player covered in this report.
The major players covered in Induced Pluripotent Stem Cells are:
Fujifilm Holding Corporation
Acelity Holdings
Bristol-Myers Squibb Company
Astellas Pharma
Aastrom Biosciences
Fate Therapeutics
Japan Tissue Engineering
Celgene Corporation
ViaCyte
StemCells
Organogenesis
Table of Contents
1 Induced Pluripotent Stem Cells Market Overview
1.1 Product Overview and Scope of Induced Pluripotent Stem Cells
1.2 Classification of Induced Pluripotent Stem Cells by Type
1.2.1 Global Induced Pluripotent Stem Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Induced Pluripotent Stem Cells Revenue Market Share by Type in 2019
1.2.3 Hepatocytes
1.2.4 Fibroblasts
1.2.5 Keratinocytes
1.2.6 Amniotic Cells
1.2.7 Others
1.3 Global Induced Pluripotent Stem Cells Market by Application
1.3.1 Overview: Global Induced Pluripotent Stem Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Academic Research
1.3.3 Drug Development And Discovery
1.3.4 Toxicity Screening
1.3.5 Regenerative Medicine
1.4 Global Induced Pluripotent Stem Cells Market by Regions
1.4.1 Global Induced Pluripotent Stem Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Induced Pluripotent Stem Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Induced Pluripotent Stem Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Induced Pluripotent Stem Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Induced Pluripotent Stem Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Induced Pluripotent Stem Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Induced Pluripotent Stem Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Fujifilm Holding Corporation
2.1.1 Fujifilm Holding Corporation Details
2.1.2 Fujifilm Holding Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Fujifilm Holding Corporation SWOT Analysis
2.1.4 Fujifilm Holding Corporation Product and Services
2.1.5 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 Acelity Holdings
2.2.1 Acelity Holdings Details
2.2.2 Acelity Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Acelity Holdings SWOT Analysis
2.2.4 Acelity Holdings Product and Services
2.2.5 Acelity Holdings Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb Company SWOT Analysis
2.3.4 Bristol-Myers Squibb Company Product and Services
2.3.5 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Astellas Pharma SWOT Analysis
2.4.4 Astellas Pharma Product and Services
2.4.5 Astellas Pharma Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 Aastrom Biosciences
2.5.1 Aastrom Biosciences Details
2.5.2 Aastrom Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Aastrom Biosciences SWOT Analysis
2.5.4 Aastrom Biosciences Product and Services
2.5.5 Aastrom Biosciences Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Fate Therapeutics
2.6.1 Fate Therapeutics Details
2.6.2 Fate Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Fate Therapeutics SWOT Analysis
2.6.4 Fate Therapeutics Product and Services
2.6.5 Fate Therapeutics Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 Japan Tissue Engineering
2.7.1 Japan Tissue Engineering Details
2.7.2 Japan Tissue Engineering Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Japan Tissue Engineering SWOT Analysis
2.7.4 Japan Tissue Engineering Product and Services
2.7.5 Japan Tissue Engineering Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Celgene Corporation
2.8.1 Celgene Corporation Details
2.8.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Celgene Corporation SWOT Analysis
2.8.4 Celgene Corporation Product and Services
2.8.5 Celgene Corporation Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 ViaCyte
2.9.1 ViaCyte Details
2.9.2 ViaCyte Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ViaCyte SWOT Analysis
2.9.4 ViaCyte Product and Services
2.9.5 ViaCyte Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 StemCells
2.10.1 StemCells Details
2.10.2 StemCells Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 StemCells SWOT Analysis
2.10.4 StemCells Product and Services
2.10.5 StemCells Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Organogenesis
2.11.1 Organogenesis Details
2.11.2 Organogenesis Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Organogenesis SWOT Analysis
2.11.4 Organogenesis Product and Services
2.11.5 Organogenesis Induced Pluripotent Stem Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Induced Pluripotent Stem Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Induced Pluripotent Stem Cells Players Market Share
3.2.2 Top 10 Induced Pluripotent Stem Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Induced Pluripotent Stem Cells Revenue and Market Share by Regions
4.2 North America Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
4.5 South America Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
5 North America Induced Pluripotent Stem Cells Revenue by Countries
5.1 North America Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
5.2 USA Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
6 Europe Induced Pluripotent Stem Cells Revenue by Countries
6.1 Europe Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
6.2 Germany Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
6.3 UK Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
6.4 France Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Induced Pluripotent Stem Cells Revenue by Countries
7.1 Asia-Pacific Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
7.2 China Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
7.5 India Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
8 South America Induced Pluripotent Stem Cells Revenue by Countries
8.1 South America Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
8.2 Brazil Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Induced Pluripotent Stem Cells by Countries
9.1 Middle East & Africa Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Induced Pluripotent Stem Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Induced Pluripotent Stem Cells Market Forecast by Type (2019-2024)
10.3 Hepatocytes Revenue Growth Rate (2015-2025)
10.4 Fibroblasts Revenue Growth Rate (2015-2025)
10.5 Keratinocytes Revenue Growth Rate (2015-2025)
10.6 Amniotic Cells Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Induced Pluripotent Stem Cells Market Segment by Application
11.1 Global Induced Pluripotent Stem Cells Revenue Market Share by Application (2015-2020)
11.2 Induced Pluripotent Stem Cells Market Forecast by Application (2019-2024)
11.3 Academic Research Revenue Growth (2015-2020)
11.4 Drug Development And Discovery Revenue Growth (2015-2020)
11.5 Toxicity Screening Revenue Growth (2015-2020)
11.6 Regenerative Medicine Revenue Growth (2015-2020)
12 Global Induced Pluripotent Stem Cells Market Size Forecast (2021-2025)
12.1 Global Induced Pluripotent Stem Cells Market Size Forecast (2021-2025)
12.2 Global Induced Pluripotent Stem Cells Market Forecast by Regions (2021-2025)
12.3 North America Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
12.4 Europe Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
12.6 South America Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Induced Pluripotent Stem Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Induced Pluripotent Stem Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Induced Pluripotent Stem Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Induced Pluripotent Stem Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Fujifilm Holding Corporation Corporate Information, Location and Competitors
Table 6. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Major Business
Table 7. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 8. Fujifilm Holding Corporation SWOT Analysis
Table 9. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Product and Solutions
Table 10. Fujifilm Holding Corporation Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Acelity Holdings Corporate Information, Location and Competitors
Table 12. Acelity Holdings Induced Pluripotent Stem Cells Major Business
Table 13. Acelity Holdings Induced Pluripotent Stem Cells Total Revenue (USD Million) (2018-2019)
Table 14. Acelity Holdings SWOT Analysis
Table 15. Acelity Holdings Induced Pluripotent Stem Cells Product and Solutions
Table 16. Acelity Holdings Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Major Business
Table 19. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb Company SWOT Analysis
Table 21. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Product and Solutions
Table 22. Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Astellas Pharma Corporate Information, Location and Competitors
Table 24. Astellas Pharma Induced Pluripotent Stem Cells Major Business
Table 25. Astellas Pharma Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 26. Astellas Pharma SWOT Analysis
Table 27. Astellas Pharma Induced Pluripotent Stem Cells Product and Solutions
Table 28. Astellas Pharma Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Aastrom Biosciences Corporate Information, Location and Competitors
Table 30. Aastrom Biosciences Induced Pluripotent Stem Cells Major Business
Table 31. Aastrom Biosciences Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 32. Aastrom Biosciences SWOT Analysis
Table 33. Aastrom Biosciences Induced Pluripotent Stem Cells Product and Solutions
Table 34. Aastrom Biosciences Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Fate Therapeutics Corporate Information, Location and Competitors
Table 36. Fate Therapeutics Induced Pluripotent Stem Cells Major Business
Table 37. Fate Therapeutics Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 38. Fate Therapeutics SWOT Analysis
Table 39. Fate Therapeutics Induced Pluripotent Stem Cells Product and Solutions
Table 40. Fate Therapeutics Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Japan Tissue Engineering Corporate Information, Location and Competitors
Table 42. Japan Tissue Engineering Induced Pluripotent Stem Cells Major Business
Table 43. Japan Tissue Engineering Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 44. Japan Tissue Engineering SWOT Analysis
Table 45. Japan Tissue Engineering Induced Pluripotent Stem Cells Product and Solutions
Table 46. Japan Tissue Engineering Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Celgene Corporation Corporate Information, Location and Competitors
Table 48. Celgene Corporation Induced Pluripotent Stem Cells Major Business
Table 49. Celgene Corporation Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 50. Celgene Corporation SWOT Analysis
Table 51. Celgene Corporation Induced Pluripotent Stem Cells Product and Solutions
Table 52. Celgene Corporation Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. ViaCyte Corporate Information, Location and Competitors
Table 54. ViaCyte Induced Pluripotent Stem Cells Major Business
Table 55. ViaCyte Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 56. ViaCyte SWOT Analysis
Table 57. ViaCyte Induced Pluripotent Stem Cells Product and Solutions
Table 58. ViaCyte Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. StemCells Corporate Information, Location and Competitors
Table 60. StemCells Induced Pluripotent Stem Cells Major Business
Table 61. StemCells Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 62. StemCells SWOT Analysis
Table 63. StemCells Induced Pluripotent Stem Cells Product and Solutions
Table 64. StemCells Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Organogenesis Corporate Information, Location and Competitors
Table 66. Organogenesis Induced Pluripotent Stem Cells Major Business
Table 67. Organogenesis Induced Pluripotent Stem Cells Total Revenue (USD Million) (2017-2018)
Table 68. Organogenesis SWOT Analysis
Table 69. Organogenesis Induced Pluripotent Stem Cells Product and Solutions
Table 70. Organogenesis Induced Pluripotent Stem Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Induced Pluripotent Stem Cells Revenue (Million USD) by Players (2015-2020)
Table 72. Global Induced Pluripotent Stem Cells Revenue Share by Players (2015-2020)
Table 73. Global Induced Pluripotent Stem Cells Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Induced Pluripotent Stem Cells Revenue Market Share by Regions (2015-2020)
Table 75. North America Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
Table 76. North America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Table 77. Europe Induced Pluripotent Stem Cells Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Induced Pluripotent Stem Cells Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Induced Pluripotent Stem Cells Revenue by Countries (2015-2020)
Table 80. South America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Induced Pluripotent Stem Cells Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Table 83. Global Induced Pluripotent Stem Cells Revenue (Million USD) by Type (2015-2020)
Table 84. Global Induced Pluripotent Stem Cells Revenue Share by Type (2015-2020)
Table 85. Global Induced Pluripotent Stem Cells Revenue Forecast by Type (2021-2025)
Table 86. Global Induced Pluripotent Stem Cells Revenue by Application (2015-2020)
Table 87. Global Induced Pluripotent Stem Cells Revenue Share by Application (2015-2020)
Table 88. Global Induced Pluripotent Stem Cells Revenue Forecast by Application (2021-2025)
Table 89. Global Induced Pluripotent Stem Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Induced Pluripotent Stem Cells Picture
Figure 2. Global Induced Pluripotent Stem Cells Revenue Market Share by Type in 2019
Figure 3. Hepatocytes Picture
Figure 4. Fibroblasts Picture
Figure 5. Keratinocytes Picture
Figure 6. Amniotic Cells Picture
Figure 7. Others Picture
Figure 8. Induced Pluripotent Stem Cells Revenue Market Share by Application in 2019
Figure 9. Academic Research Picture
Figure 10. Drug Development And Discovery Picture
Figure 11. Toxicity Screening Picture
Figure 12. Regenerative Medicine Picture
Figure 13. Global Induced Pluripotent Stem Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Induced Pluripotent Stem Cells Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Induced Pluripotent Stem Cells Revenue Market Share in 2019
Figure 22. Global Top 10 Players Induced Pluripotent Stem Cells Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Induced Pluripotent Stem Cells Revenue Market Share by Regions (2015-2020)
Figure 26. Global Induced Pluripotent Stem Cells Revenue Market Share by Regions in 2018
Figure 27. North America Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 28. Europe Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 30. South America Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 32. North America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Figure 33. North America Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure 34. USA Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 35. Canada Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 37. Europe Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure 39. Germany Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 40. UK Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 41. France Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 42. Russia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 43. Italy Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure 46. China Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 47. Japan Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 48. Korea Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 49. India Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 51. South America Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Figure 52. South America Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure 53. Brazil Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 58. UAE Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Induced Pluripotent Stem Cells Revenue and Growth Rate (2015-2020)
Figure 61. Global Induced Pluripotent Stem Cells Revenue Share by Type (2015-2020)
Figure 62. Global Induced Pluripotent Stem Cells Revenue Share by Type in 2019
Figure 63. Global Induced Pluripotent Stem Cells Market Share Forecast by Type (2021-2025)
Figure 64. Global Hepatocytes Revenue Growth Rate (2015-2020)
Figure 65. Global Fibroblasts Revenue Growth Rate (2015-2020)
Figure 66. Global Keratinocytes Revenue Growth Rate (2015-2020)
Figure 67. Global Amniotic Cells Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Induced Pluripotent Stem Cells Revenue Share by Application (2015-2020)
Figure 70. Global Induced Pluripotent Stem Cells Revenue Share by Application in 2019
Figure 71. Global Induced Pluripotent Stem Cells Market Share Forecast by Application (2021-2025)
Figure 72. Global Academic Research Revenue Growth Rate (2015-2020)
Figure 73. Global Drug Development And Discovery Revenue Growth Rate (2015-2020)
Figure 74. Global Toxicity Screening Revenue Growth Rate (2015-2020)
Figure 75. Global Regenerative Medicine Revenue Growth Rate (2015-2020)
Figure 76. Global Induced Pluripotent Stem Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Induced Pluripotent Stem Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Induced Pluripotent Stem Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
Figure 80. Europe Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
Figure 82. South America Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Induced Pluripotent Stem Cells Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
ヒト胚性幹細胞（HESC）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Embryonic Stem Cells (HESC) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Embry…- 化学療法誘発悪心＆嘔吐（CINV）用薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global ChemOtherapy Induced Nausea and Vomiting （CINV） Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2…
- 化学療法誘発性好中球減少症（CIN）治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Chemotherapy-Induced Neutropenia (CIN) Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. …
- 変態誘発塑性鋼の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Transformation Induced Plasticity Steel market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Trans…
- 船舶用燃料電池の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Fuel Cells for Marine Vessels market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fuel Cells for …